Eris-Lifesciences (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE lists new securities from 9 companies issued under Employee Stock Option Plans (ESOP/ESOS), effective for trading from May 20, 2026. | |||||||||||||||
BSE lists new securities from 9 companies issued under Employee Stock Option Plans (ESOP/ESOS), effective for trading from May 20, 2026.
| |||||||||||||||
BSE notifies listing and trading permission for 23,06,372 new equity shares of Eris Lifesciences Limited issued on preferential basis to … | |||||||||||||||
BSE notifies listing and trading permission for 23,06,372 new equity shares of Eris Lifesciences Limited issued on preferential basis to non-promoters, effective March 10, 2026.
| |||||||||||||||
BSE notifies listing of 23,06,372 new equity shares of Eris Lifesciences Limited on a preferential basis to non-promoters, effective March … | |||||||||||||||
BSE notifies listing of 23,06,372 new equity shares of Eris Lifesciences Limited on a preferential basis to non-promoters, effective March 10, 2026, with a lock-in period until February 14, 2029.
| |||||||||||||||
BSE lists 23,06,372 new equity shares of Eris Lifesciences Limited on preferential basis, effective March 10, 2026, with lock-in until … | |||||||||||||||
BSE lists 23,06,372 new equity shares of Eris Lifesciences Limited on preferential basis, effective March 10, 2026, with lock-in until February 14, 2029.
| |||||||||||||||